Adefovir-induced Stevens-Johnson syndrome and toxic epidermal necrolysis overlap syndrome.

Journal Title: Singapore Medical Journal - Year 2011, Vol 52, Issue 2

Abstract

An increasing number of patients with chronic hepatitis B infection are being treated with the newly licensed drug, adefovir. It is an acyclic nucleoside phosphonate that is relatively safe in the dosage generally used for chronic hepatitis B. Serious adverse cutaneous drug reactions like Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) following adefovir use have not been reported. We report a case of adefovir-induced SJS and TEN overlap syndrome in a patient with chronic hepatitis B infection.

Authors and Affiliations

P Chattopadhyay, N Sarma

Keywords

Related Articles

Cholestasis and biliary dilatation associated with chronic ketamine abuse: a case series.

Ketamine is a dissociative anaesthetic agent that is still widely used in veterinary and human medicine. It is increasingly being used as a recreational hallucinogenic drug. Chronic ketamine abuse is known to account for...

Fish bone-induced hepatic abscess: medical treatment.

We report a case of a 59-year-old man admitted for acute myocardial infarction. He subsequently spiked a high-grade fever on the second day after percutaneous coronary intervention. Computed tomography imaging of the abd...

Sleep duration and its correlates in a sample of Saudi elementary school children.

INTRODUCTION: This study was conducted to estimate sleep duration in Saudi elementary school children, sleep habits and practices that may affect it, and compare our results to published data in other societies. METHODS:...

Download PDF file
  • EP ID EP129541
  • DOI -
  • Views 111
  • Downloads 0

How To Cite

P Chattopadhyay, N Sarma (2011). Adefovir-induced Stevens-Johnson syndrome and toxic epidermal necrolysis overlap syndrome.. Singapore Medical Journal, 52(2), 31-34. https://europub.co.uk/articles/-A-129541